Skip to main content
NMRA logo

NMRA · Neumora Therapeutics, Inc. · Share Buybacks

Track NMRA — free
$0.33 -0.01 (-3.78%) At close · Nov 20 Play latest call Q4 2025 earnings call transcript
Market Cap
$63.01M
Shares
188.69M
Volume · Nov 20 1.06M Avg daily vol (3M) 1.67M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2024-10 $300,000,000 — —
Key facts CIK 1885522 CUSIP 640979100 13F (30d) 143 filings 117 filers Visit website Investor relations